Literature DB >> 23395239

Changes in epidemiologic features of testicular germ cell cancer: age at diagnosis and relative frequency of seminoma are constantly and significantly increasing.

Christian G Ruf1, Hendrik Isbarn2, Walter Wagner3, Margit Fisch2, Cord Matthies3, Klaus-Peter Dieckmann4.   

Abstract

OBJECTIVES: Testicular germ cell tumors (GCTs) have their incidence peak in the third and fourth decades of life. Histologically, GCTs comprise of seminoma and nonseminoma at almost equal proportions with a slight preponderance of nonseminoma in most of the major series. Since decades, there is a shift toward decreasing age at presentation. Recently, there are suggestions of a reversal of the age trend, and also, the histologic subtype ratio appears to shift toward seminoma. We retrospectively looked to our patient populations to verify these recent trends.
METHODS: A total of 2,482 patients with histologically proven GCT diagnosed between 1976 and 2010 were retrospectively evaluated regarding the year of diagnosis, histology of primary tumor, and age at presentation. Patients were categorized according to the following time periods of treatment: before 1990, 1990 to 1994, 1995 to 1999, 2000 to 2004, and 2005 to 2010. Mean age and relative proportion of seminoma were compared among patient categories by employing the chi-square test and analysis of variance, respectively.
RESULTS: The mean age significantly increased from 28 to 36 years. The age difference between the 2 histologic subtypes remained constant between 6 and 8 years during the entire observation period. The relative proportion of seminoma continuously increased from 30.9% to 56% (P <0.001).
CONCLUSION: There is evidence of a significant shift toward older age at diagnosis of GCT. In addition, the proportion of seminoma is constantly increasing at the expense of nonseminoma. The reasons for these developments are obscure. However, 2 old theories regarding the pathogenesis of GCT may receive support from our results: first, the theory of divergent pathogenetic pathways of seminoma and nonseminoma and second, the involvement of postnatal environmental factors in the pathogenesis of GCTs.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Age at diagnosis; Epidemiology; Nonseminoma; Seminoma; Testicular germ cell tumor

Mesh:

Year:  2013        PMID: 23395239     DOI: 10.1016/j.urolonc.2012.12.002

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  32 in total

1.  Administration of high-dose chemotherapy with stem cell support in patients 40 years of age or older with advanced germ cell tumours: a retrospective study from the European Society for Blood and Marrow Transplantation database.

Authors:  A Necchi; S Lo Vullo; G Rosti; M Badoglio; P Giannatempo; D Raggi; S Secondino; L Mariani; F Lanza; P Pedrazzoli
Journal:  Bone Marrow Transplant       Date:  2017-06-05       Impact factor: 5.483

2.  Testicular cancer: changing patterns of incidence in testicular germ cell tumours.

Authors:  Mausam Singhera; Robert Huddart
Journal:  Nat Rev Urol       Date:  2013-04-23       Impact factor: 14.432

Review 3.  Management of Germ Cell Tumours of the Testis in Adult Patients. German Clinical Practice Guideline Part I: Epidemiology, Classification, Diagnosis, Prognosis, Fertility Preservation, and Treatment Recommendations for Localized Stages.

Authors:  Sabine Kliesch; Stefanie Schmidt; Doris Wilborn; Clemens Aigner; Walter Albrecht; Jens Bedke; Matthias Beintker; Dirk Beyersdorff; Carsten Bokemeyer; Jonas Busch; Johannes Classen; Maike de Wit; Klaus-Peter Dieckmann; Thorsten Diemer; Anette Dieing; Matthias Gockel; Bernt Göckel-Beining; Oliver W Hakenberg; Axel Heidenreich; Julia Heinzelbecker; Kathleen Herkommer; Thomas Hermanns; Sascha Kaufmann; Marko Kornmann; Jörg Kotzerke; Susanne Krege; Glen Kristiansen; Anja Lorch; Arndt-Christian Müller; Karin Oechsle; Timur Ohloff; Christoph Oing; Ulrich Otto; David Pfister; Renate Pichler; Heinrich Recken; Oliver Rick; Yvonne Rudolph; Christian Ruf; Joachim Schirren; Hans Schmelz; Heinz Schmidberger; Mark Schrader; Stefan Schweyer; Stefanie Seeling; Rainer Souchon; Christian Winter; Christian Wittekind; Friedemann Zengerling; Dirk-Henrik Zermann; Roger Zillmann; Peter Albers
Journal:  Urol Int       Date:  2021-01-07       Impact factor: 2.089

4.  Histopathological Trends of Testicular Neoplasm: An Experience over a Decade in a Tertiary Care Centre in the Malwa Belt of Central India.

Authors:  Preeti Rihal Chakrabarti; Shilpi Dosi; Amit Varma; Priyanka Kiyawat; Gaurav Khare; Sandeep Matreja
Journal:  J Clin Diagn Res       Date:  2016-06-01

Review 5.  Will Testicular Germ Cell Tumors Remain Untargetable?

Authors:  Fouad Aoun; Hampig Raphael Kourie; Simone Albisinni; Thierry Roumeguère
Journal:  Target Oncol       Date:  2016-12       Impact factor: 4.493

Review 6.  The genomic landscape of testicular germ cell tumours: from susceptibility to treatment.

Authors:  Kevin Litchfield; Max Levy; Robert A Huddart; Janet Shipley; Clare Turnbull
Journal:  Nat Rev Urol       Date:  2016-06-14       Impact factor: 14.432

7.  Thromboprophylaxis and the route of administration of chemotherapy in testicular cancer patients in German-speaking countries.

Authors:  Tim Nestler; Johannes Huber; Adrienne M Laury; Hendrik Isbarn; Axel Heidenreich; Hans U Schmelz; Christian G Ruf
Journal:  World J Urol       Date:  2018-02-07       Impact factor: 4.226

8.  Testicular Germ-Cell Tumours: A Descriptive Analysis of Clinical Characteristics at First Presentation.

Authors:  Klaus-Peter Dieckmann; Hanna Richter-Simonsen; Magdalena Kulejewski; Raphael Ikogho; Henrik Zecha; Petra Anheuser; Uwe Pichlmeier; Hendrik Isbarn
Journal:  Urol Int       Date:  2018-04-12       Impact factor: 2.089

Review 9.  Contemporary management of stage I and II seminoma.

Authors:  Peter Chung; Padraig Warde
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

10.  Supraclavicular left neck mass: an unusual presentation of metastatic testicular cancer in two older men.

Authors:  Chinnoi Law; Zainab AlshiekhAli; Nicholas Taylor; David Howlett
Journal:  BMJ Case Rep       Date:  2020-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.